Аннотация:In non-healing diabetic ulcers (diabetic foot) auto-transplantation (a common treatment
approach) is not effective due to impaired fibroblast functionality and shifts in synthesis of ECM proteins (COL1, COL3, FN) and certain growth factors. It was shown that HIF1 (hypoxia-induced factor) is a key regulator of ECM remodeling by fibroblasts through control of collagen prolyl hydroxylase (P4HA1, P4HA2 e both required for collagen deposition) and
lysylhydroxylase (PLOD2 emodulates collagen fibers strength) expression. Therefore, the use
of hypoxia-stimulated fibroblasts (sFbs) may represent a reasonable treatment alternative in the maintenance of chronic diabetic wounds. Here, we evaluated the expression levels of
wound healing-related genes and proteins in sFbs after 24h, 48h and 72h exposure to 1% O2.
After a short-term (24/48h) exposure to hypoxia, sFbs exhibited a marked increase in
expression of a number of genes as compared to 21% O2 culture: Hif1a e7.4 and 16.9 fold
respectively; Vegf1a e21/60; Egln1 e9/9; Egln2 e6.5/5; Egln3 e53/110; COL1 e2.4/3; Fn
e 3.3/1.7; P4HAa1 - 5.8/7.8; P4ha2 e 6.6/8.5; and Plod2 - 9/25 fold. In contrast, with a
longer exposure to hypoxia (72h), activation was significantly diminished (Hif1a e 2 fold;
Vegf1a e6; Egln3 e2.4) or completely abrogated (Egln1, Egln2, COL1, Fn, P4ha1, P4ha2,
and Plod2). Importantly, at protein level, we observed only COLI (2 fold) stimulation by
hypoxia. The stimulation of COLIII and Fn synthesis in sFb was detected only after a 6-18h period of their re-oxygenation. Based on our results, we propose that short-term stimulation of dermal fibroblasts (for example, immobilized on a biopolymer scaffold) by hypoxia could be beneficial for chronic diabetic wound treatment.